Thijs Vincent N, Brachmann Johannes, Morillo Carlos A, Passman Rod S, Sanna Tommaso, Bernstein Richard A, Diener Hans-Christoph, Di Lazzaro Vincenzo, Rymer Marilyn M, Hogge Laurence, Rogers Tyson B, Ziegler Paul D, Assar Manish D
From the Florey Institute of Neuroscience and Mental Health and Austin Health Department of Neurology (V.N.T.), Heidelberg, Australia; Hospital Klinikum Coburg (J.B.), Teaching Hospital of the University of Würzburg, Coburg, Germany; Population Health Research Institute (C.A.M.), McMaster University, Hamilton, Canada; Northwestern University Feinberg School of Medicine (R.S.P.), Chicago, IL; Institute of Cardiology (T.S.), Catholic University of the Sacred Heart, Rome, Italy; Davee Department of Neurology (R.A.B.), Northwestern University, Chicago, IL; Department of Neurology (H.-C.D.), University Hospital Essen University Duisburg-Essen, Germany; Institute of Neurology (V.D.L.), University Campus Bio-Medico of Rome, Rome, Italy; University of Kansas Medical Center (M.M.R.), Kansas City; Medtronic (L.H.), Maastricht, Netherlands; Medtronic (T.B.R., P.D.Z.), Mounds View, Minneapolis, MN; and Baylor University Medical Center (M.D.A.), Dallas, TX.
Neurology. 2016 Jan 19;86(3):261-9. doi: 10.1212/WNL.0000000000002282. Epub 2015 Dec 18.
We assessed predictors of atrial fibrillation (AF) in cryptogenic stroke (CS) or transient ischemic attack (TIA) patients who received an insertable cardiac monitor (ICM).
We studied patients with CS/TIA who were randomized to ICM within the CRYSTAL AF study. We assessed whether age, sex, race, body mass index, type and severity of index ischemic event, CHADS2 score, PR interval, and presence of diabetes, hypertension, congestive heart failure, or patent foramen ovale and premature atrial contractions predicted AF development within the initial 12 and 36 months of follow-up using Cox proportional hazards models.
Among 221 patients randomized to ICM (age 61.6 ± 11.4 years, 64% male), AF episodes were detected in 29 patients within 12 months and 42 patients at 36 months. Significant univariate predictors of AF at 12 months included age (hazard ratio [HR] per decade 2.0 [95% confidence interval 1.4-2.8], p = 0.002), CHADS2 score (HR 1.9 per one point [1.3-2.8], p = 0.008), PR interval (HR 1.3 per 10 milliseconds [1.2-1.4], p < 0.0001), premature atrial contractions (HR 3.9 for >123 vs 0 [1.3-12.0], p = 0.009 across quartiles), and diabetes (HR 2.3 [1.0-5.2], p < 0.05). In multivariate analysis, age (HR per decade 1.9 [1.3-2.8], p = 0.0009) and PR interval (HR 1.3 [1.2-1.4], p < 0.0001) remained significant and together yielded an area under the receiver operating characteristic curve of 0.78 (0.70-0.85). The same predictors were found at 36 months.
Increasing age and a prolonged PR interval at enrollment were independently associated with an increased AF incidence in CS patients. However, they offered only moderate predictive ability in determining which CS patients had AF detected by the ICM.
我们评估了接受植入式心脏监测器(ICM)的不明原因卒中(CS)或短暂性脑缺血发作(TIA)患者发生心房颤动(AF)的预测因素。
我们研究了在CRYSTAL AF研究中被随机分配接受ICM的CS/TIA患者。我们使用Cox比例风险模型评估年龄、性别、种族、体重指数、首次缺血事件的类型和严重程度、CHADS2评分、PR间期以及糖尿病、高血压、充血性心力衰竭、卵圆孔未闭和房性早搏的存在是否能预测随访最初12个月和36个月内AF的发生。
在221例随机接受ICM的患者中(年龄61.6±11.4岁,64%为男性),12个月内有29例患者检测到AF发作,36个月时有42例。12个月时AF的显著单因素预测因素包括年龄(每十年风险比[HR]2.0[95%置信区间1.4 - 2.8],p = 0.002)、CHADS2评分(每增加1分HR 1.9[1.3 - 2.8],p = 0.008)、PR间期(每10毫秒HR 1.3[1.2 - 1.4],p < 0.0001)、房性早搏(四分位数中>123次与0次相比HR 3.9[1.3 - 12.0],p = 0.009)以及糖尿病(HR 2.3[1.0 - 5.2],p < 0.05)。在多因素分析中,年龄(每十年HR 1.9[1.3 - 2.8],p = 0.0009)和PR间期(HR 1.3[1.2 - 1.4],p < 0.0001)仍然显著,二者共同得出的受试者工作特征曲线下面积为0.78(0.70 - 0.85)。在36个月时发现了相同的预测因素。
入组时年龄增加和PR间期延长与CS患者AF发生率增加独立相关。然而,它们在确定哪些CS患者通过ICM检测到AF方面仅具有中等预测能力。